Showing results (1011-1020 of 1,116) with videos related to
Sort By:
Pageof 112
Nature Immunology|March 15, 2024
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccinationValeria Fumagalli, Micol Ravà, Davide Marotta, et al.Immunity|May 1, 2020
The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and HumansJohn L Johnson, Rebecca L Rosenthal, James J Knox, et al.Gastrointestinal Endoscopy|June 3, 2008
Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trialCraig A Solem, Edward V Loftus, Joel G Fletcher, et al.Nature Biomedical Engineering|May 20, 2025
Treatment of a metabolic liver disease in mice with a transient prime editing approachTanja Rothgangl, András Tálas, Eleonora I Ioannidi, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 TrialBarbara H McGovern, Christopher B Ford, Matthew R Henn, et al.Biorxiv : the Preprint Server for Biology|January 5, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.JAMA Network Open|February 13, 2023
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm TrialMatthew D Sims, Sahil Khanna, Paul Feuerstadt, et al.Proceedings of the National Academy of Sciences of the United States of America|February 2, 2020
Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrierOscar A Marcos-Contreras, Colin F Greineder, Raisa Yu Kiseleva, et al.Cell Host & Microbe|December 11, 2020
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to NeutralizationDrew Weissman, Mohamad-Gabriel Alameh, Thushan de Silva, et al.Science Translational Medicine|March 3, 2023
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in miceJamile Ramos da Silva, Karine Bitencourt Rodrigues, Guilherme Formoso Pelegrin, et al.Pageof 112